SCHEMBL6284455

SCHEMBL6284455

Cn1ccc2c(ncn2-c2cccc(-c3ccccc3C#N)c2)c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 7/20 0.56
▸ GABRG2 P18507 7/20 0.56
▸ GABRB3 P28472 7/20 0.56
▸ GABRA5 P31644 5/20 0.56
▸ GABRA3 P34903 5/20 0.56
▸ GABRA2 P47869 4/20 0.41
▸ GRIA1 P42261 1/20 0.41
▸ GRIA3 P42263 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GRM1 Q13255 3/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4003028 0.86 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6923332 0.83 GABRA1 (0.48) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6283855 0.76 GABRA1 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6283846 0.74 GABRA1 (0.52) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1762157 0.74 GABRA1 (0.70) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1761798 0.74 GABRA1 (0.69) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL29642847 0.74 GABRA1 (0.49) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL17940732 0.74 GABRA1 (0.49) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2190248 0.73 GABRA1 (0.85) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1616062 0.72 GABRA1 (0.66) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887885-B2 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands MERCK SHARP & DOHME LTD 2005-05-03 — — US claimed
US-6887885-B2 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands MERCK SHARP & DOHME LTD 2005-05-03 — — US disclosed
US-20040132767-A1 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands MERCK SHARP & DOHME LTD. (GB) 2004-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132767-A1 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands GABRA1, GABRA2, GABRA3 GABRA1 1/4885GABRG2 21/4885GABRB3 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback